Marc Denayer Email & Phone Number
Head Pharmacovigilance @ Agomab Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Marc Denayer Location
- Leuven, Flanders, BE
Marc Denayer Work
- 2025 -now Head Pharmacovigilance @
- 2024 -2025 Head of Pharmacovigilance, Estetra SRL, a wholly owned subsidiary of Gedeon Richter Plc @
- 2021 -2024 Head of Pharmacovigilance @
- 2015 -2021 Global Head Drug Safety and Medical Affairs @
- 2014 -2015 Medical Director @
- 2009 -2014 Member of the Board of Directors @
- 2008 -2014 Vice-President Pharmacovigilance and Medical Compliance @ Janssen-Cilag Europe, Middle-East & Africa
- 2005 -2008 EMEA Head Pharmacovigilance and Medical Compliance @ Janssen-Cilag Europe, Middle-East & Africa
- 2001 -2005 Senior Director Medical Affairs @ Janssen-Cilag Europe, Middle-East & Africa
- 2000 -2001 Manager Medical Affairs @
- 1998 -2000 Associate Director, International Pharmacovigilance @
- 1990 -1998 Head, Clinical Safety – Vaccines @ SmithKline Beecham Biologicals, Rixensart, Belgium
- 1987 -1990 Academic Assistant @ Institute of Hygiene, Epidemiology Unit
Marc Denayer Education
- Fellow of Belgian College of Pharmaceutical Medicine
Physician Specialist in Pharmaceutical Medicine (Physician Specialist in Pharmaceutical Medicine)
2001-2017 - Faculteit Geneeskunde KU Leuven Faculty of Medicine
Medical Doctor (Medical Doctor)
1979-1986
Marc Denayer Skills
- Medicine
- Pharmaceutical Industry
- Therapeutic Areas
- Vaccines
- Medical Affairs
- Pharmacovigilance
- Epidemiology
- Evidence-based Medicine
- Quality Management
- Risk Management
- Organizational Development
- People Development
- Evidence-based Management
- Goal Oriented
- Process Improvement
- Networking
- Knowledge Sharing
- GCP
- Capability Development
- Leading transformational change
- High Performance Teams
- Driving Business Growth
- Cost Reduction Solutions
- Clinical Research
- Life Sciences
- Oncology
- Regulatory Affairs
- Biotechnology
- Drug Safety
- Marketing
- Evidence Based Management
- Management
- Project Management
- Evidence Based Medicine
- Microsoft Word
- PowerPoint
- Social Media
- Clinical Trials
- Good Clinical Practice Gcp
- Good Clinical Practice
Marc Denayer Summary
- Marc Denayer, based in Leuven, Flanders, BE, is currently a Head Pharmacovigilance at Agomab. Marc Denayer brings experience from previous roles at Richter Gedeon Nyrt. / Magyarország, Mithra, Oxurion NV and MSD Belgium bvba/sprl. Marc Denayer holds a 2001 - 2017 Physician Specialist in Pharmaceutical Medicine in Physician Specialist in Pharmaceutical Medicine @ Fellow of Belgian College of Pharmaceutical Medicine. With a robust skill set that includes Medicine, Pharmaceutical Industry, Therapeutic Areas, Vaccines, Medical Affairs and more. Marc Denayer has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Marc Denayer?
Find contact details for 700 million professionals.
Others Named Marc Denayer
Marc Denayer
Manager
Antwerp, BE
Top Agomab Therapeutics Employees
Imme van der Taelen
Head of Development
Mechelen, BE
Philippe Wiesel
Chief Medical Officer
Arlington, MA, US
Remco van Den Burg
Head of Quality
Amsterdam, NH, NL
Geert Winnen
IMP Supplies Management
Antwerp, BE
Marc Denayer
Head Pharmacovigilance
Leuven, Flanders, BE
Malene Watzinger
Head of Preclinical Safety
Pantin, FR
Andrea Sáez Borderías
Chief Development Officer
Barcelona, CT, ES
Ellen Lefever
General Counsel
Antwerp, BE
Andreea Vasilachi
Head of FP and A
Leuven, Flanders, BE
Tim Knotnerus
CEO
Amsterdam, NH, NL
Kirsten Eisenloeffel
Head of Procurement
Netherlands
Hannah Dams
Corporate Controller
Antwerp, BE
Xavier van Rillaer
Head of Finance and Controlling
Mechelen, BE
Mirjam Bollema
Head of People
Netherlands
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co